Smoking and Cancer Risk: Which Cancers Are Linked and by How Much

Lung cancer gets most of the attention when smoking and cancer are discussed. But cigarettes cause at least 16 different types of cancer — and for several of them, smoking is the dominant causal factor. Understanding the full picture changes how you think about the stakes of quitting.

The Overall Cancer Burden

Cigarette smoking is the leading cause of preventable cancer death in most developed countries. In the UK, it causes approximately 35,000 cancer deaths per year. In the US, approximately 480,000 deaths per year from all smoking-related causes, with cancer representing a large proportion.

The Carcinogen Mechanism

Cigarette smoke contains approximately 70 known carcinogens. The major categories:

Polycyclic aromatic hydrocarbons (PAHs): Including benzo[a]pyrene, these form DNA adducts — covalent bonds with DNA bases — that, if not repaired, produce mutations. The TP53 tumor suppressor gene is particularly commonly mutated by PAH-induced adducts in smokers' lung tumors.

Tobacco-specific nitrosamines (TSNAs): Including NNK and NNN, these are formed during tobacco curing and combustion. They're potent lung carcinogens that activate carcinogen-metabolizing enzymes and produce reactive metabolites that damage DNA.

Benzene: Associated with leukemia — benzene metabolites intercalate into DNA and cause chromosomal aberrations.

Polonium-210: A radioactive element in cigarette smoke that emits alpha particles, which are particularly effective at causing double-strand DNA breaks.

Formaldehyde and acetaldehyde: Reactive aldehydes that form DNA adducts and inhibit DNA repair.

Cancer Risk by Site

Lung Cancer

The dominant smoking-related cancer. Smokers have approximately 15–30x (1,500–3,000%) higher risk of lung cancer than non-smokers — the relative risk depends on lifetime pack-years.

Mechanism: Direct bronchial epithelial exposure to carcinogens; cilia damage reducing carcinogen clearance; immune suppression
Histologies: Smoking is associated with squamous cell carcinoma and small cell carcinoma most strongly; adenocarcinoma risk is also elevated but relatively less so
Risk after quitting: Halved at 5–10 years; continues declining but never reaches never-smoker baseline

Oral Cavity and Pharynx

Smokers have 5–10x higher risk of cancers of the mouth, tongue, gums, and pharynx. The carcinogen contact in the mouth is direct.

Combined alcohol and tobacco use multiplies the risk dramatically (synergistic, not just additive)
Risk returns to near-normal within 10 years of cessation

Laryngeal Cancer

10–20x higher risk in smokers. The larynx (voice box) is directly exposed to cigarette smoke. Heavy alcohol use combined with smoking increases risk further.

Esophageal Cancer

2–6x higher risk (squamous cell carcinoma type more strongly associated than adenocarcinoma). The esophagus is exposed to both inhaled smoke and swallowed carcinogens.

Bladder Cancer

4–7x higher risk in smokers. Mechanism: carcinogens (particularly aromatic amines) are processed by the liver, concentrated in urine, and stored in the bladder — the epithelium is in prolonged contact with carcinogens. Risk decreases after quitting but declines more slowly than lung or oral cancers.

Kidney Cancer

2–3x higher risk. Carcinogens reach the kidneys through blood filtration.

Pancreatic Cancer

2–4x higher risk. The precise mechanism is less well understood, but smoking is the most consistently identified modifiable risk factor for pancreatic cancer.

Cervical Cancer

1.5–2x higher risk. Cigarette smoke carcinogens are found in cervical mucus of smokers. Smoking also impairs local immune clearance of HPV, the virus responsible for cervical cancer — suggesting that smoking acts as a co-factor rather than independent cause.

Leukemia

Smokers have 1.5–2x higher risk of acute myeloid leukemia (AML). Mechanism: benzene's hematological toxicity.

Colorectal Cancer

1.5–2x higher risk. The mechanism involves ingested carcinogens and systemic effects of smoke compounds on intestinal epithelium.

Stomach Cancer

1.5–2x higher risk.

Liver Cancer

1.5–2.5x higher risk. Smoking is an independent liver cancer risk factor even after controlling for alcohol use.

How Quickly Does Cancer Risk Drop After Quitting?

The key physiological process: after quitting, cells replace themselves over their normal turnover cycles without ongoing carcinogen exposure. Pre-malignant cells with repairable DNA damage undergo programmed cell death or immunological clearance. This takes time.

Cancer Type	Risk Reduction at 5 years	Risk Reduction at 10 years
Lung	~50%	~30–50% of current smoker risk
Oral/Pharynx	Substantial	Near non-smoker
Esophageal	Significant	Near non-smoker
Bladder	Modest	Moderate (slow clearance)
Cervical	Moderate	Significant

The Dose-Response Relationship

Cancer risk scales with both intensity (cigarettes per day) and duration (years of smoking). Pack-years (cigarettes per day x years ÷ 20) is the standard measure. Risk scales non-linearly — duration of smoking appears to matter more than daily quantity.

A person who smoked 40 cigarettes a day for 10 years has higher lung cancer risk than someone who smoked 20 a day for 20 years — even with the same pack-year count. Duration appears to be the more important variable.

FAQ

What percentage of smokers get cancer?

Approximately 15–20% of heavy smokers develop lung cancer over their lifetime. Most smoking-related cancer deaths (not just lung) account for roughly 50% of long-term heavy smokers dying of smoking-attributable causes. Not every smoker gets cancer, but the risk accumulates significantly with each pack-year.

What is the biggest cancer risk from smoking?

Lung cancer in absolute terms — both the relative risk (15–30x normal) and the total mortality. But smoking causes at least 15 other cancer types, and the combined burden across these is substantial.

Does switching to e-cigarettes reduce cancer risk?

Yes — e-cigarettes don't produce combustion products, so the carcinogen exposure is dramatically lower than cigarettes. Current evidence suggests substantially reduced cancer risk from vaping compared to smoking, though long-term data is limited. Quitting all nicotine products remains the safest option.